Dergiler / Anatolian Current Medical Journal / 2022 / Cilt: 4 - Sayı: 3

Cardiac effects of Sugammadex and Rocuronium combination in rats: experimental study

Sayfa
244–248
Yayın Tarihi
2022-07-26
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Although sugammadex and sugammadex-rocuronıum complex cause biochemical and histopathological effect on the heart tissue, there were no irreversible histopathologic changes and no significant biochemical difference found in this study.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: In this experimental study, it was aimed to examine the effects of rocuronium and sugammadex complex on cardiac muscle cells in rats histopathologically and biochemically.
📊
Temel Bulgular & Veri:Matherial and Method: 32 adult Sprague-Dawley male rats were divided into four groups with 8 in each group.
💡
Sonuç & Katkı:Conclusion: Although sugammadex and sugammadex-rocuronıum complex cause biochemical and histopathological effect on the heart tissue, there were no irreversible histopathologic changes and no significant biochemical difference found in this study.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Sugammadex · rocuronium · cardiac muscle

Abstract

Aim: In this experimental study, it was aimed to examine the effects of rocuronium and sugammadex complex on cardiac muscle cells in rats histopathologically and biochemically. Matherial and Method: 32 adult Sprague-Dawley male rats were divided into four groups with 8 in each group. Group 1 consisted of animals that did not undergo surgical treatment. Group 2 received a volume equivalent to 16 mg/kg sugammadex with 0.9% intravenous saline. Group 3 received 16 mg/kg of intravenous sugammadex. Group 4, 1 mg/kg intravenous rocuronium and 16 mg/kg intravenous sugammadex were administered to rats. After the procedure completed GSH and MDA level evaluated biochemically; and heart tissue evaluated histopathologically. Results: In group 4, connective tissue edema between muscle fibers was observed to be significantly increased, vessel dilatation and hemorrhagic areas were observed. Groups 3 and 4 were found to cause an increase in GSH level when compared to Groups 1 and 2, and a decrease in MDA level in these two groups compared to the others. Conclusion: Although sugammadex and sugammadex-rocuronıum complex cause biochemical and histopathological effect on the heart tissue, there were no irreversible histopathologic changes and no significant biochemical difference found in this study.

🔖

Bu Makaleye Atıf Yap

DOĞUKAN, M., YILMAZ, N., ANNAÇ, E., DOĞAN, Z., ÜÇKARDEŞ, F., ULUDAG, Ö. (2022). Cardiac effects of Sugammadex and Rocuronium combination in rats: experimental study. Anatolian Current Medical Journal, Cilt: 4 - Sayı: 3, 244–248. https://ajindex.com/articles/733747

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Fisher DM. Clinical pharmacology of neuromuscular blocking agents. Am J Health Syst Pharm 1999; 56: 4–9. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: Reversal of neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth 2006; 96: 201-6.
  2. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemi-cal encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-70.
  3. Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth 2016; 35: 1-12.
  4. Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2018; 73: 631-41.
  5. Abad-Gurumeta A, Ripollés-Melchor J, Casans-Francés R, et al.A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia 2015; 70: 1441-52.
  6. Won YJ, Lim BG, Lee DK, Kim H, Kong MH, Lee IO. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: a systematic review and meta-analysis. Medicine (Baltimore) 2016; 95: e4678. Lee W. The potential risks of sugammadex. Anesth Pain Med 2019; 14: 117-22. Uludağ Ö. Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: Experimental study. KafkasUniv Vet Fak Derg 2019; 25: 793-9.
  7. Miller MA, Zachary JF. Mechanisms and morphology of cellular injury, adaptation, and death. In: Pathologic Basis of Veterinary Disease. Elsevier; 2017. p. 2-43.e19. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissue by TBA test. AnalBiochem1978; 86: 271-8. Elman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
  8. Cammu G, De Kam PJ, Demeyer I, et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaest 2008; 100: 373–9.
  9. De Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: A multi center, dose-finding and safety study. Anesthesiology 2007; 107: 239–44.
  10. Osaka Y, Shimada N, Satou